Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2209)
All Articles published online
|
Aug 1, 2004 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gong GZ, Jiang YF, He Y, Lai LY, Zhu YH, Su XS. HCV NS5A abrogates p53 protein function by interfering with p53-DNA binding. World J Gastroenterol 2004; 10(15): 2223-2227 [PMID: 15259070 DOI: 10.3748/wjg.v10.i15.2223] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i15/2223.htm |
| Number | Citing Articles |
| 1 |
Elham Shirvani-Dastgerdi, Robert E Schwartz, Alexander Ploss. Hepatocarcinogenesis associated with hepatitis B, delta and C viruses. Current Opinion in Virology 2016; 20: 1 doi: 10.1016/j.coviro.2016.07.009
|
| 2 |
Clara Balsano, Anna Alisi. Hepatitis C virus (HCV): an RNA virus with a pro-oncogenic potential. Digestive and Liver Disease 2007; 39: S46 doi: 10.1016/S1590-8658(07)80010-7
|
| 3 |
Sharon Sheahan, Christopher O Bellamy, Stephen N Hartland, David J Harrison, Sandrine Prost. TGFbeta induces apoptosis and EMT in primary mouse hepatocytes independently of p53, p21
Cip1 or Rbstatus. BMC Cancer 2008; 8(1) doi: 10.1186/1471-2407-8-191
|
| 4 |
Maria Lina Tornesello, Luigi Buonaguro, Franco M Buonaguro. An overview of new biomolecular pathways in pathogen-related cancers. Future Oncology 2015; 11(11): 1625 doi: 10.2217/fon.15.87
|
| 5 |
Johannes G. Bode, Erwin D. Brenndörfer, Dieter Häussinger. Subversion of innate host antiviral strategies by the hepatitis C virus. Archives of Biochemistry and Biophysics 2007; 462(2): 254 doi: 10.1016/j.abb.2007.03.033
|
| 6 |
Updesh Dixit, Ashutosh K. Pandey, Zhihe Liu, Sushil Kumar, Matthew B. Neiditch, Kenneth M. Klein, Virendra N. Pandey, J.-H. J. Ou. FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53. Journal of Virology 2015; 89(15): 7905 doi: 10.1128/JVI.00729-15
|
| 7 |
Qi Wang, Yongsheng Wang, Yue Li, Xuesong Gao, Shunai Liu, Jun Cheng. NS5ATP9 Contributes to Inhibition of Cell Proliferation by Hepatitis C Virus (HCV) Nonstructural Protein 5A (NS5A) via MEK/Extracellular Signal Regulated Kinase (ERK) Pathway. International Journal of Molecular Sciences 2013; 14(5): 10539 doi: 10.3390/ijms140510539
|
| 8 |
Francesco Bellanti, Juan Sastre, Gaetano Serviddio. Systems Biology of Free Radicals and Antioxidants. 2014; : 1809 doi: 10.1007/978-3-642-30018-9_141
|
| 9 |
Dipankar Chattopadhyay, Helen Reeves. Textbook of Hepatology. 2007; : 391 doi: 10.1002/9780470691861.ch3e
|
| 10 |
Sharon Sheahan, Christopher O Bellamy, Donald R Dunbar, David J Harrison, Sandrine Prost. Deficiency of G1 regulators P53, P21Cip1and/or pRb decreases hepatocyte sensitivity to TGFβ cell cycle arrest. BMC Cancer 2007; 7(1) doi: 10.1186/1471-2407-7-215
|
| 11 |
Claire Gondeau, Lydiane Pichard-Garcia, Patrick Maurel. Cellular models for the screening and development of anti-hepatitis C virus agents. Pharmacology & Therapeutics 2009; 124(1): 1 doi: 10.1016/j.pharmthera.2009.05.010
|
| 12 |
Valeria Di Vuolo, Luigi Buonaguro, Francesco Izzo, Simona Losito, Gerardo Botti, Franco M Buonaguro, Maria Lina Tornesello. TP 53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients. Infectious Agents and Cancer 2011; 6(1) doi: 10.1186/1750-9378-6-13
|
| 13 |
Heena B Choudhary, Satish K Mandlik, Deepa S Mandlik. Role of p53 suppression in the pathogenesis of hepatocellular carcinoma. World Journal of Gastrointestinal Pathophysiology 2023; 14(3): 46-70 doi: 10.4291/wjgp.v14.i3.46
|
| 14 |
Eun Mi Choi, So Ra Kim, Eun Jeong Lee, Jeong A. Han. Cyclooxygenase-2 functionally inactivates p53 through a physical interaction with p53. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2009; 1793(8): 1354 doi: 10.1016/j.bbamcr.2009.05.006
|
| 15 |
Benli Jia, Dongsheng Yu, Gang Yu, Yunsheng Cheng, Yang Wang, Xiaoqiang Yi, Xiaoping Li, Yong Wang. Naringenin improve hepatitis C virus infection induced insulin resistance by increase PTEN expression via p53-dependent manner. Biomedicine & Pharmacotherapy 2018; 103: 746 doi: 10.1016/j.biopha.2018.04.110
|
| 16 |
Giorgia di Bello, Gianluigi Vendemiale, Francesco Bellanti. Redox cell signaling and hepatic progenitor cells. European Journal of Cell Biology 2018; 97(8): 546 doi: 10.1016/j.ejcb.2018.09.004
|
| 17 |
Francesco Bellanti, Giuseppe Pannone, Nicola Tartaglia, Gaetano Serviddio. Redox Control of the Immune Response in the Hepatic Progenitor Cell Niche. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00295
|
| 18 |
Du Cheng, Lei Zhao, Leiliang Zhang, Yongfang Jiang, Yi Tian, Xinqiang Xiao, Guozhong Gong. p53 controls hepatitis C virus non-structural protein 5A-mediated downregulation of GADD45α expression via the NF-κB and PI3K–Akt pathways. Journal of General Virology 2013; 94(2): 326 doi: 10.1099/vir.0.046052-0
|
| 19 |
Sunali Mehta, Hamish Campbell, Catherine J Drummond, Kunyu Li, Kaisha Murray, Tania Slatter, Jean‐Christophe Bourdon, Antony W Braithwaite. Adaptive homeostasis and the p53 isoform network. EMBO reports 2021; 22(12) doi: 10.15252/embr.202153085
|
| 20 |
Michael A. Joyce, Kathie-Anne Walters, Sue-Ellen Lamb, Mathew M. Yeh, Lin-Fu Zhu, Norman Kneteman, Jason S. Doyle, Michael G. Katze, D. Lorne Tyrrell, Grant McFadden. HCV Induces Oxidative and ER Stress, and Sensitizes Infected Cells to Apoptosis in SCID/Alb-uPA Mice. PLoS Pathogens 2009; 5(2): e1000291 doi: 10.1371/journal.ppat.1000291
|